These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Weight-based ribavirin with pegylated interferon alfa 2b: benefits, risks, and the origin of the evidence. Hrachovec J; Patel P Gastroenterology; 2003 Jun; 124(7):2003-4; author reply 2004-5. PubMed ID: 12812198 [No Abstract] [Full Text] [Related]
6. [Anti-viral therapy of type C chronic hepatitis. 3. New development in anti-viral therapy of type C chronic hepatitis--Peg-IFN/ribavirin combination therapy and a new anti-viral treatment]. Hiramatsu N Nihon Naika Gakkai Zasshi; 2008 Jan; 97(1):75-81. PubMed ID: 18360974 [No Abstract] [Full Text] [Related]
7. [Healing of chronic hepatitis C following 12 weeks of therapy with peginterferon-alpha and ribavirin]. Barreales M; Castellano G; Fernández I; Muñoz R; Manzano M; Solís Herruzo JA Rev Esp Enferm Dig; 2007 Dec; 99(12):738-40. PubMed ID: 18290706 [No Abstract] [Full Text] [Related]
8. Summaries for patients. Duration and dose of antiviral treatment for chronic hepatitis C. Ann Intern Med; 2004 Mar; 140(5):I67. PubMed ID: 14996694 [No Abstract] [Full Text] [Related]
9. Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C. Sagir A; Wettstein M; Heintges T; Häussinger D Dig Dis Sci; 2002 Mar; 47(3):562-3. PubMed ID: 11911342 [No Abstract] [Full Text] [Related]
10. The substantial role of initial ribavirin dose on the response to peginterferon alpha/ribavirin therapy in patients with genotype 1b chronic hepatitis C. Dai CY; Huang CF; Chuang WL; Huang JF; Yu ML Am J Gastroenterol; 2009 Sep; 104(9):2358-9. PubMed ID: 19727098 [No Abstract] [Full Text] [Related]
11. Hepatitis C viral kinetics as a determinant of stopping pegylated interferon and ribavirin in genotype 1 infection. Kim DY Gut Liver; 2014 Jul; 8(4):335-6. PubMed ID: 25071896 [No Abstract] [Full Text] [Related]
12. Do differences in pegylation of interferon alfa matter? Zeuzem S Gastroenterology; 2010 Jan; 138(1):34-6. PubMed ID: 19932662 [No Abstract] [Full Text] [Related]
13. Side effects of therapy for chronic hepatitis C. Russo MW; Fried MW Gastroenterology; 2003 May; 124(6):1711-9. PubMed ID: 12761728 [No Abstract] [Full Text] [Related]
14. Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL. Lo Nigro L; La Spina M; Mirabile E; Pisana P; Schilirò G; Guardo P Pediatr Blood Cancer; 2004 Aug; 43(2):185. PubMed ID: 15236293 [No Abstract] [Full Text] [Related]